Advertisement
Research Article

BALB/c Mice Infected with Antimony Treatment Refractory Isolate of Leishmania braziliensis Present Severe Lesions due to IL-4 Production

  • Diego L. Costa,

    Affiliation: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

    X
  • Vanessa Carregaro,

    Affiliation: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

    X
  • Djalma S. Lima-Júnior,

    Affiliation: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

    X
  • Neide M. Silva,

    Affiliation: Biomedical Sciences Institute, Federal University of Uberlândia, Uberlândia, Brazil

    X
  • Cristiane M. Milanezi,

    Affiliation: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

    X
  • Cristina R. Cardoso,

    Affiliation: Department of Biological Sciences, Federal University of Triângulo Mineiro, Uberaba, Brazil

    X
  • Ângela Giudice,

    Affiliation: Immunology Service, Professor Edgar Santos Universitary Hospital, Federal University of Bahia, Salvador, Brazil

    X
  • Amélia R. de Jesus,

    Affiliation: Department of Internal Medicine and Pathology, Federal University of Sergipe, Aracajú, Brazil

    X
  • Edgar M. Carvalho,

    Affiliation: Immunology Service, Professor Edgar Santos Universitary Hospital, Federal University of Bahia, Salvador, Brazil

    X
  • Roque P. Almeida,

    Affiliation: Department of Internal Medicine and Pathology, Federal University of Sergipe, Aracajú, Brazil

    X
  • João S. Silva mail

    jsdsilva@fmrp.usp.br

    Affiliation: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

    X
  • Published: March 01, 2011
  • DOI: 10.1371/journal.pntd.0000965

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.